Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies. Oster P, Vaillant L, Riva E, McMillan B, et al. Gut 2021 Jul 12. pii: gutjnl-2020-323392. doi: 10.1136/gutjnl-2020-323392.

Read + Share

Amedeo Smart

Independent Medical Education

Oster P, Vaillant L, Riva E, McMillan B, et al. Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies. Gut 2021 Jul 12. pii: gutjnl-2020-323392. doi: 10.1136/gutjnl-2020-323392.
PMID: 34253574